(Q46444482)

22 December 2017

title

Serum antibodies to putative proteinase maturation protein A in children with acute otitis media (English)

1 reference

22 December 2017

1 reference

Anni Vainio

1

1 reference

22 December 2017

Riku Fagerlund

2

1 reference

22 December 2017

Krister Melén

3

1 reference

22 December 2017

Markus J Lehtinen

4

1 reference

22 December 2017

Ilkka Julkunen

5

1 reference

22 December 2017

Anni Virolainen

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

25 October 2005

1 reference

22 December 2017

published in

Vaccine

1 reference

22 December 2017

volume

24

1 reference

22 December 2017

issue

11

1 reference

22 December 2017

page(s)

1792-1799

1 reference

22 December 2017

Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Novel pneumococcal surface proteins: role in virulence and vaccine potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Pneumococcal virulence factors: structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Differential protein expression in phenotypic variants of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

PspC, a pneumococcal surface protein, binds human factor H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Novel purification scheme and functions for a C3-binding protein from Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Detection of 23 immunogenic pneumococcal proteins using convalescent-phase serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Complete Genome Sequence of a Virulent Isolate of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Comparison of serum antibodies to pneumolysin with those to pneumococcal capsular polysaccharides in children with acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.034

10.1016/J.VACCINE.2005.10.034

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017